|
Development of Plasma-based Surgical Tools: ArthroCare has developed a novel electrosurgical technology using a plasma to etch tissue rather than creating a pyrolytic effect like conventional electro-surgery. Although initially developed for cardiology, the technology was first applied in arthroscopic surgery and then in cosmetic, ENT, spine, neurosurgery, and many others. It is now the standard of care for several arthroscopic procedures and is used in almost 30% of tonsillectomies in the U.S. This proprietary technology has very interesting effects on tissue: not only does it provide minimal thermal margin, but Coblation can induce creation of neo-vascularization and promote tissue healing and regeneration. These properties are used clinically to treat various degenerative diseases. Jean Woloszko is the Vice President for Research and Development and Chief Scientific and Technology Officer at ArthroCare Corp. in Sunnyvale, CA. He is directing a team of over 85 people to research, design, and develop new products including plasma surgery tools, various types of implants and anchors, surgical tools for sports medicine, ENT surgery, spine surgery, urology, neurosurgery, and other fields of medicine. He earned a Ph.D. in Bioengineering from the University of Illinois at Chicago in 1992 and his M.D. from the University of Montpelier (France) in 1985. He is certified in Rehabilitation Medicine and Biomechanics. He has held research positions since 1981 at INSERM U103 Laboratory (Montpelier, France), Illinois Institute of Technology, the University of Illinois at Chicago, and the Bakken Research Center of Medtronic, Inc. (Maastricht, the Netherlands). He joined ArthroCare in 1998 as Medical Director. He holds over 20 patents and is the author of over 48 articles, proceedings, or abstracts. |
||
|